This study was aimed at determining serotonin (5-hydroxytryptamine: 5HT) receptor subtypes participating in 5HT-induced response in the isolated corpus cavernosum penis (CCP) of rabbits. 5HT contracted the CCP in a concentration-dependent manner. Both WAY100635 (5HT 1A antagonist) and LY53857 (5HT 2 antagonist) concentration-dependently suppressed the 5HT-induced contraction. The suppression of the 5HT-induced contraction by ketanserin (5HT 2A antagonist) was weaker than that by LY53857. LY278584 (5HT 3 antagonist) did not affect the 5HT-induced contraction. SDZ205557 (5HT 4 antagonist) showed a tendency to potentiate the 5HT-induced contraction. The above results suggest that 5HT 1A and 5HT 2 receptor subtypes partially participate in the contractile response to 5HT in rabbit CCP, and the potentiation by SDZ205557 of the 5HT-induced contraction implies the existence of dual contractile and relaxing responses to 5HT via 5HT 1 and 5HT 2 , and 5HT 4 receptors, respectively. The relaxing response to 5HT 4 receptor stimulation may be masked by 5HT-induced contraction.
Introduction
Serotonin (5-hydroxytryptamine: 5HT) receptors are classified into seven different subtypes (5HT 1, 2, 3, 4, 5, 6, 7 ) , and 5HT 1 and 5HT 2 receptors are, respectively, subdivided into five subtypes (5HT 1A, 1B, 1D, 1E, 1F ) and into three subtypes (5HT 2A, 2B, 2C ). 1 Fenfluramine (5HT-releasing agent) and 5-hydroxytryptophan (5HT precursor) with the peripheral decarboxylase inhibitor induce the penile erection through the central nervous system in rats. 2 This penile erection is induced by stimulation of the 5HT 1C receptor, 3 which is now recognized as 5HT 2C receptor. 1 The stimulation of 5HT 1A or 5HT 2 receptor by administration of 5HT agonists inhibits the penile erection in rats. 3 It is unknown whether peripheral administration of 5HT agonists in vivo shows the penile erection via central and/or peripheral mechanisms. The erection is caused by the relaxation of corpus cavernosum penis (CCP). We previously reported that 5HT caused the contraction in the isolated CCP of rabbits. 4 Therefore, 5HT agonists may inhibit peripherally the penile erection and the contractile response to 5HT in vitro may be opposite against the penile erectile response to 5HT via central 5HT receptor in vivo. In human CCP, 5HT 4 agonist causes the relaxation, which is not suppressed by selective 5HT 4 antagonist. 5 It has not been shown whether subtype of 5HT receptor could participate in the contractile response in CCP. This study was aimed at determining which subtype of 5HT receptor could participate in the 5HT-induced contraction in rabbit CCP. In this study, we used five selective 5HT receptor subtype antagonists, WAY100635 (5HT 1A ), 6 LY53857 (5HT 2 ), 7 ketanserin (5HT 2A ), 8 LY278584 (5HT 3 ), 9 SDZ205557 (5HT 4 ) 10 for determining their antagonistic effects on the 5HT-induced contraction.
Materials and methods

Tissue preparation
Male Japanese White rabbits, weighing 3.0-4.0 kg, were killed by exsanguination under general anesthesia with urethane (1.3 g/kg, i.p.). Penises were surgically removed en bloc. The urethra and connective tissues were excised freely from CCP. Four preparations of CCP All antagonists were present in the bath 10 min before the 5HT administration.
Data analysis and statistics
All values were expressed as the mean7s.e.m. Statistical significance was determined by paired Student's t-test, Dunnett's multiple comparison test or two-way analysis of variance followed by Bonferroni's test. P-values less than 0.05 were considered to be significant.
Results
We summed up a classification of 5HT receptor subtypes and our results in Table 1 . 5HT (0.1 mM-1 mM) contracted the CCP in a concentration-dependent manner. However, we could not perform the experiment at concentrations over 1 mM of 5HT because of its solubility, to which contractile response was not maximum. The apparent EC 50 value of 5HT obtained from the first concentration-response curve, in which maximum response (100%) was postulated at its concentration of 1 mM, was 108.2 (95% confidence limits: 88.5-142.2) mM. The maximum response of 5HT was about 84.6% of that of phenylephrine. 15 There were no significant differences among four concentrationresponse curves of 5HT and the maximum responses of 5HT obtained by four times repetition ( Figure 1 ). WAY100635 (5HT 1A antagonist) concentration-dependently (0.1-10 mM) and significantly (1 and 10 mM: Po0.01 by ANOVA) suppressed the 5HT-induced contraction (Figure 2 ). Although the concentration-response curves of 5HT in the presence of 1 and 10 mM of WAY100635 were reversed, there was no significant difference between both the curves. LY53857 (5HT 2 antagonist) concentration-dependently (0.1-10 mM) and significantly (10 mM: Po0.01 by ANOVA) suppressed the 5HT-induced contraction ( Figure 3 ). The significant (10 mM: Po0.01 by ANOVA) suppression of the 5HT-induced contraction by ketanserin (5HT 2A antagonist) ( Figure 4 ) was weaker than that by LY53857 (Figure 7 ). LY278584 Antagonists for 5HT receptor subtypes are referred to references 6-14. F: absence of selective antagonist. Effects of antagonists on the 5HT-induced contraction: suppression (--, ---, ----), potentiation (+), no effect (B). ND: not determined in this study.
Responses to 5HT in CCP of rabbit K Furukawa et al (5HT 3 antagonist) did not affect the 5HT-induced contraction ( Figure 5 ). SDZ205557 (5HT 4 antagonist) showed a tendency to potentiate the 5HT-induced contraction, which was not significant (Figure 6 ). WAY100635 and LY53857 (1 mM) significantly (Po0.01, Po0.05, respectively) suppressed the 5HT (100 nM)-induced contraction, but ketanserin, LY278584 and SDZ205557 did not ( Figure 7 ).
Discussion
5HT contracted the rabbit CCP in a concentrationdependent manner and did not show any relaxations. We did three times administration of 5HT before getting the control concentration-response curves (first: check of response, second and third: confirming stable responses) and then we obtained four concentration-response curves by four times repetition. There were no significant differences among the four concentration-response curves and their maximum responses. Therefore, we obtained stable concentration-response curves of 5HT for the experiments with 5HT antagonists. The apparent EC 50 value (108.2 mM) of 5HT was about 15 times larger than that (7.4 mM) of phenylephrine (a 1 agonist) in the rabbit CCP. 15 Although pA 2 values of a 1A antagonists (5-methylurapidil, WB4101 and tamsulosin) are 7-9 in the rabbit CCP Responses to 5HT in CCP of rabbit K Furukawa et al and those of 5HT antagonists used could not be calculated in this study, the pA 2 of WAY100635 which showed the strongest and incomplete antagonism at 1 and 10 mM in this study is supposed to be below 6. These results indicate that, in normal condition, the sympathetic nervous system is more important for the erectile function than 5HT system. It has been shown that 5HT has inhibitory effect on sexual function in the central nervous system 16 and selective serotonin re-uptake inhibitors (SSRIs), which accumulate 5HT in the nerve endings and potentiate the effect of 5HT, cause sexual dysfunctions such as decrease of sexual desire (libido) and orgasm, ejaculatory and erectile dysfunctions. 17 As 5HT can contract the CCP preparation at about 85% of phenylephrine-induced contraction, SSRIs may contract CCP via their peripheral action to increase 5HT level. Namely, SSRIs peripherally have the possibility of causing the erectile dysfunction. On the other hand, p-chloroamphetamine (5HT-releasing agent) causes penile erection and ejaculation in anesthetized rats, which are limited to the lower spinal cord and/or peripheral sites. 18 Therefore, there is a difference in peripheral action of 5HT between in vivo and in vitro experiments. Experiments used with SSRIs are in progress.
WAY100635 strongly suppresses the 5HT-induced contraction. WAY100635 is the highly selective 5HT 1A antagonist. 6, 19 Therefore, 5HT 1A receptor partially participates in the 5HT-induced contraction in rabbit CCP. 5HT 1 receptor family mainly couples to G i /G o -type of G-protein and the stimulation of 5HT 1 receptors inhibits adenylyl cyclase. 1 5HT 1A receptor stimulation does not release endothelium-derived relaxing factor and increase cAMP, of which both substances relax smooth muscles.
1 Therefore, the stimulation of 5HT 1A receptor results in CCP contraction. The efficacy of WAY100635 was apparently reversed between the concentrations of 1 and 10 mM. If 5HT has a relaxing effect via the other 5HT receptor subtypes which WAY100635 blocks at its higher concentration (10 mM), it might be supposed that WAY100635 suppresses the 5HT-induced relaxation. These may explain that the reversed concentration-response curves of 5HT in the presence of 1 and 10 mM of WAY100635 is as a result of suppression of masked relaxation. In this experiment, we could not show whether other 5HT 1 receptor subtypes participate in the 5HT-induced contraction. Further experiments are in progress. Not only LY53857 (a potent 5HT 2 receptor antagonist) but also ketanserin (5HT 2A receptor antagonist) suppressed the 5HT-induced contraction. The suppression by ketanserin seems to be weaker than that by LY53857, because LY53857 (1 mM) suppressed the 5HT (100 nM)-induced contraction, but the same concentration of ketanserin Responses to 5HT in CCP of rabbit K Furukawa et al did not. Therefore, 5HT 2 receptors involved with 5HT 2A receptor may partially participate in the 5HT-induced contraction. 5HT 2 receptors mainly couples to G q /G 11 -type of G-protein and the stimulation of 5HT 2 receptors activates phospholipase C. 1 These signal transduction mechanisms cause the contraction of the smooth muscle. From the above results, the antagonistic effects of WAY100635 and LY53857 suggest that both 5HT 1A and 5HT 2 receptors may participate in the 5HT-induced contraction. This hypothesis is supported by a report that the stimulation of 5HT 1A or 5HT 2 receptor inhibits the penile erection by administration of 5HT agonists in rats. 3 We are investigating whether 5HT 2B and/or 5HT 2C receptors participate in the 5HT-induced contraction. Lack of effect of LY278584 (a potent 5HT 3 receptor antagonist 8 ) on the concentrationresponse curve of 5HT suggests that 5HT 3 receptor does not participate in the 5HT-induced contraction. SDZ205557 (5HT 4 receptor antagonist) showed a tendency to potentiate the 5HT-induced contraction. A similar result of relaxation induced by 5HT was reported in the canine colon longitudinal muscle. 20 Since SDZ205557 has similar affinity for both 5HT 3 and 5HT 4 receptors, 21 and 5HT 3 receptor does not participate in 5HT-induced contraction in this study, the potentiation by SDZ205557 of the 5HT-induced contraction in this study may imply the existence of dual responses to 5HT as contraction and relaxation in rabbit CCP. 5HT 4 receptor subtype may participate in the relaxation masked by 5HT-induced contraction via the other 5HT receptor subtype. The potentiation by SDZ205557 of the 5HT-induced contraction approves that 5HT 4 agonist causes the relaxation in human CCP. 5 
Conclusions
5HT 1A and 5HT 2 receptor subtypes partially participate in the contractile response to 5HT and 5HT 4 receptor subtype participates in the relaxation masked by 5HT-induced contraction in rabbit CCP. The potentiation by 5HT 4 receptor antagonist of the 5HT-induced contraction may imply the existence of dual responses to 5HT as contraction and relaxation in rabbit CCP. The drug development of selective 5HT 1A and 5HT 2 receptor antagonists and/or 5HT 4 receptor agonists in CCP may have therapeutic advantages for erectile dysfunction owing to peripheral disorders of 5HT system.
